Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Ipilimumab shows significant survival benefits in stage IV melanoma patients, with a median survival of 10 months. The FDA grants priority review status to this cancer treatment, providing new hope for those with devastating disease.
The University of Louisville has received a $1.5 million NIH grant to develop an interdisciplinary oncology palliative care education program. The program will integrate the services of physicians, nurses, chaplains, and social workers to provide comprehensive care to cancer patients.
Researchers at Dana-Farber Cancer Institute found that multivitamin use did not impact colon cancer outcomes in patients with stage III colon cancer. Multivitamin use had no beneficial effect on patients' survival rates but may have a small association with survival benefits for younger patients and those who are obese.
A pilot study suggests psilocybin, a hallucinogen, is safe and effective in improving mood and reducing anxiety in patients with advanced-stage cancer. The treatment resulted in improved anxiety scores and a depression inventory revealed an improvement of mood that began two weeks after treatment.
A team of researchers discovered HMGB1 as a critical pro-autophagic protein that enhances cell survival and limits programmed cell death. This finding suggests blocking HMGB1 could benefit cancer patients by preventing tumor cells from revving up autophagy to withstand chemotherapy, immunotherapy, and radiation treatment
A recent study found that Mexican-origin women are more likely to be diagnosed with breast cancer at younger ages and have higher mortality rates than non-Hispanic white women. The research highlights the need for tailored prevention and education strategies to address these disparities.
Researchers at TGen have identified two potential anti-cancer drug targets, STK10 and TNK2, for Ewing's sarcoma in children. These kinases play a crucial role in the growth and survival of cancer cells, making them promising therapeutic targets.
A new targeted therapy called PLX4032 has been linked to an 80% response rate in treating advanced melanoma. The treatment, which targets the BRAF protein, has shown significant tumor shrinkage and improved quality of life for some patients.
A new analysis found that rectal cancer rates are rising among young people under 40, with a 3.8% annual increase between 1984 and 2005. The study suggests that endoscopic evaluation should be considered for individuals presenting with rectal bleeding or other signs of the disease.
A new study has demonstrated that combining a specific drug with radiotherapy significantly improves treatment outcomes for cervical cancer patients. The research found that the addition of cisplatin to radiotherapy reduces the likelihood of death by 23%, leading to improved survival rates.
A phase 3 trial found trastuzumab improves median survival to 13.8 months for HER2-positive advanced gastric cancer patients, with a 26% reduction in death rate compared to chemotherapy alone. The treatment's cost effectiveness is questioned due to its estimated £13,857 per patient cost and $55,000 cost per life-year gained.
Chronic health conditions are widespread among stem cell transplant survivors, with 66% reporting at least one condition and 35% experiencing three or more. Chronic graft-versus-host disease also increases the risk of severe or life-threatening conditions.
Palliative care significantly improved the lives of lung cancer patients, extending their survival by an average of 11.6 months compared to those receiving standard care alone. Quality-of-life assessments also showed substantial improvement in the palliative care group.
Researchers at Beth Israel Deaconess Medical Center discovered that the MDM2 oncogene is regulated by a complex signaling pathway involving enzymes CKI and beta-TRCP1. This finding suggests a 'dimmer switch' control mechanism, which could lead to new drug targets for killing tumors.
A recent study published in Blood journal of American Society of Hematology found that cancer cells can contaminate ovarian tissue in women with leukemia, making fertility preservation methods unsafe. The study suggests that cancer cells from acute and chronic leukemias can be present in frozen-thawed ovarian tissue.
A study of over 80,000 patients in the UK found no significant association between oral bisphosphonate use and an increased risk of esophageal or gastric cancer. The analysis excluded patients with less than 6 months follow-up, resulting in 41,826 members in each group.
The UK government's £50 million emergency cancer fund is under fire for its potential to favor patients based on geographical location rather than medical need. The Lancet Editorial argues that this policy undermines the principles of evidence-based medicine and rational healthcare resource allocation.
The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center has attained NCI designation, recognizing its innovative research and excellent patient care. The center will receive a $7.5 million support grant over five years to advance cancer research and provide patients access to promising new treatments.
A new study found that socioeconomic status predicts survival of Canadian cancer patients, with those from poorer backgrounds facing higher mortality rates. The study also suggests that factors such as cancer biology and access to treatment may play a role in these disparities.
Researchers developed an alphavirus vector to overcome neutralizing antibodies and Tregs, inducing clinically relevant immune responses in patients with metastatic cancer. Repeated administration led to longer overall patient survival, making the approach a promising therapeutic option.
Researchers at Duke University Medical Center developed an experimental vaccine that stimulates an immune response against tumor growth. In a Phase I/II study, the vaccine showed promising results in patients with advanced lung, colon, breast, and pancreatic cancers.
Researchers found that albumin and serum protein parameters are less sensitive than anthropometric measurements for evaluating nutritional status in gastric cancer patients. However, a good correlation was observed between scoring nutritional assessment tools and other general nutritional measurement tools six months after surgery.
A new lab test developed by Japanese scientists can accurately predict imatinib resistance in chronic myeloid leukemia (CML) patients. The test measures protein levels and activity markers to identify resistant cells and determine the next therapeutic option, including dose escalation or combination therapy.
A new study published in The Lancet found that women who underwent radiation therapy as children are more likely to experience stillbirths or baby deaths when attempting to conceive. In contrast, no increased risk was found for men exposed to similar levels of radiation. The authors suggest that uterine damage may be the primary factor...
The GRB7 gene is found to drive an aggressive form of breast cancer and acts independently of the HER-2 gene. Isolating its role could help fine-tune treatment and enable accurate prognoses.
A telephone-based care management program improved cancer patients' pain and depression by 30% and 50%, respectively. The program, which combined telephonic care management with automated symptom monitoring, showed better outcomes for several health-related quality of life domains.
A new prediction tool calculates individualized risk for local recurrence five and ten years after surgery, helping physicians and patients weigh treatment options. The nomogram integrates available information to estimate absolute risk, providing a valuable tool in decision-making.
A new study has found that centralized telephone-based care management can significantly reduce pain and depression in cancer patients. The INCPAD study combined automated calls with follow-up calls from nurse care managers, and the results showed improved outcomes for patients with all types of cancers.
A recent study found that ultra-low-molecular-weight heparin semuloparin reduces the incidence of venous thromboembolism (VTE) and all-cause death by 25% in orthopedic surgery patients compared to enoxaparin.
The European Society for Medical Oncology (ESMO) has published updated clinical practice guidelines for cancer care, providing vital information on diagnosis, treatment plans, and follow-up. The new guidelines cover various tumor types and include expanded sections on cardiotoxicity and fertility considerations.
A new study finds that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer. EUS evaluation was found to improve overall survival, possibly due to earlier cancer detection and more selective surgery. The study analyzed a large population-based cancer registry and demonstrated the...
Researchers have found a potential link between autoimmune disease scleroderma and cancer in certain patients. The study suggests that patients with specific immune markers are more likely to develop both conditions simultaneously.
Researchers found that black patients are more likely to be diagnosed with advanced cancer and receive inadequate treatment. The study attributes these disparities to patient trust issues, lack of access to quality care, and limited resources at hospitals serving primarily black patients.
The Arizona Myeloma Network recognized Dr. Jeffrey Trent, President of the Translational Genomics Research Institute (TGen), for his organization's support of cancer patients and events such as the 'All Cancers' run. This recognition acknowledges TGen's involvement in patient-advocacy organizations like AzMN.
The Damon Runyon Cancer Research Foundation and Doris Duke Charitable Foundation have partnered to support Tobias J.E. Carling, a young physician-scientist with a $486,000 grant. The foundation aims to address the shortage of talented physician-scientists dedicated to translating research into breakthrough treatments.
Researchers have developed a novel assay to test for multiple tumor markers in bladder cancer using custom-designed MLPA with multiple short synthetic probes. The study found paired tumor and urine samples showed identical marker patterns, suggesting this assay may be used for non-invasive diagnosis.
A comprehensive genomic analysis of prostate cancer has identified key alterations in the androgen receptor pathway and defined subsets of low- and high-risk disease. The study provides valuable resources for cancer research and may lead to the creation of a genetic-based test to determine which tumors require aggressive treatment.
African-American women have more advanced breast cancer at diagnosis and poorer survival outcomes compared to non-Hispanic whites. Despite similar surgical care and adjuvant therapy, African-Americans experience lower overall and breast cancer-specific survival rates due to socio-demographic factors.
A new study suggests that targeted surveillance colonoscopy is cost-effective and effective in reducing colorectal cancer burden. The study recommends a 3/10 strategy of colonoscopy every three years for high-risk patients, which is more effective than no surveillance but slightly more costly.
Research suggests that biologics-naïve Juvenile Idiopathic Arthritis (JIA) patients may have an elevated risk of cancer compared to the general population. The Swedish study found a higher incidence of cancers among paediatric JIA patients identified during the last 40 years.
RG7204, a BRAF inhibitor, has shown significant preclinical activity against melanoma by inhibiting proliferation of tumor cell lines and inducing partial or complete tumor regression. The compound also improved survival rates without associated toxicity in preclinical models.
A new study reveals that disparities in cancer stage and treatment account for the majority of excess deaths among uninsured and Medicaid-insured rectal cancer patients. Improving insurance coverage and reducing cost-related barriers to primary care and high-quality treatment can help mitigate these disparities.
A recent analysis found that 18% of US cancer survivors, equating to over two million individuals, did not receive necessary medical services in the previous year due to financial worries. Cancer survivors under 65 were 55% more likely to delay or forgo all types of medical care than their non-cancer peers.
Researchers at TGen and VARI discovered a biomarker, miR-92a-2*, linked to survival in SCLC patients. Higher tumor levels of this microRNA are associated with chemoresistance and decreased survival.
A meta-analysis of publicly available data from randomised trials found that patients taking ARBs had a significantly increased likelihood of new cancer diagnosis compared with patients in control groups. The study also found a modestly increased risk of lung cancer among ARB users, but no significant excess in cancer deaths.
UAB researchers are investigating the role of inactivated DNA left behind after breast-cancer treatment. They aim to understand how this altered DNA activates cancer's deadly spread, a process called metastasis. The study could lead to improved prevention and treatment for millions of cancer patients.
A decade-long Phase III clinical trial found that selenium has no benefit in reducing the risk of developing lung cancer, either a recurrence or second primary malignancy. The study involved 1,522 Stage I non-small cell lung cancer patients and showed that selenium had minimal side effects but failed to demonstrate any protective effect.
Researchers found that cancer cells lacking COMMD1 are more invasive and likely to metastasize, suggesting a possible drug target. Enhanced COMMD1 levels in mouse melanoma cells reduced metastatic lung tumors.
Vandetanib significantly prolongs progression-free survival and improves response rates compared to standard chemotherapy alone in previously treated advanced NSCLC patients. The addition of vandetanib also reduces symptoms and increases time to worsening of symptoms.
Researchers from John Theurer Cancer Center present studies on first-line treatments for aggressive lymphoma, the efficacy of genetically engineered cancer therapy, and the value of a commonly used tool for staging lymphoma. Findings include a high complete remission rate with rituximab-FND combination therapy and better survival rates...
The John Theurer Cancer Center is presenting 16 research abstracts on various areas of oncology during the ASCO Annual Meeting. These studies include Phase I and II trials for multiple myeloma, lymphoma, and cutaneous T-cell lymphoma treatments.
Ihor S. Sawczuk, M.D., Co-Chief of the Division of Urologic Oncology, presents research on laparoscopic adrenalectomy and robot-assisted radical prostatectomy for recurrent prostate cancer. The John Theurer Cancer Center showcases its expertise in urologic oncology through these innovative treatments.
Researchers at Henry Ford Hospital found that adenocarcinoma of the bladder has a poor overall survival rate, but certain factors can improve prognosis. Patients diagnosed at age 60 or younger and those with well-differentiated, localized tumors may have better chances of survival.
Researchers tested methylphenidate, a psychostimulant medication, to treat cancer-related fatigue. While the study found no significant difference between treatment and placebo groups, there was a trend of improved satisfaction with treatment among patients receiving methylphenidate, particularly those with stage III/IV cancer.
Cancer patients can benefit from moderate-intensity aerobic exercise, tailored to individual needs, to improve quality of life, muscular strength, and reduce the risk of recurrence for breast cancer patients. Exercise also helps maintain lean body mass, contributing to increased well-being.
Researchers found that Wikipedia's cancer information is accurate but poorly readable compared to peer-reviewed sites like the National Cancer Institute's PDQ. Readability was highly statistically significant, with Wikipedia written at a college level while PDQ was suitable for a 9th grader.
Men who choose radiotherapy over surgery for prostate cancer have a 17% improvement in overall survival rate, with patients refusing treatment having a 51% 10-year survival rate. This study highlights the importance of considering treatment options when diagnosed with prostate cancer.
A new Mayo Clinic study found that complete removal of all tumors that spread can significantly improve prognosis for kidney cancer patients. Patients who underwent complete tumor removal had an average cancer-specific survival rate of 5 years, compared to just 1 year for those without metastatic tumors removed.
Research from Fox Chase Cancer Center shows that patients with stage IIIA non-small cell lung cancer (NSCLC) who receive surgery, particularly lobectomy, have increased overall survival rates. This is in contrast to those who received chemoradiation alone.
A large Phase III randomized trial of shark cartilage as a cancer agent found no survival benefit for patients with advanced non-small cell lung cancer. The study enrolled 379 newly-diagnosed patients and did not meet its primary endpoint: survival.